Eichstaedt, Christina A. and Sassmannshausen, Zoe and Shaukat, Memoona and Cao, Ding and Xanthouli, Panagiota and Gall, Henning and Sommer, Natascha and Ghofrani, Hossein-Ardeschir and Seyfarth, Hans-Juergen and Lerche, Marianne and Halank, Michael and Kleymann, Janina and Benjamin, Nicola and Harutyunova, Satenik and Egenlauf, Benjamin and Milger, Katrin and Rosenkranz, Stephan and Ewert, Ralf and Klose, Hans and Hoeper, Marius M. and Olsson, Karen M. and Lankeit, Mareike and Lange, Tobias J. and Hinderhofer, Katrin and Gruenig, Ekkehard (2022) Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension. RESPIRATORY RESEARCH, 23 (1): 74. ISSN , 1465-993X
Full text not available from this repository. (Request a copy)Abstract
Background A genetic predisposition can lead to the rare disease pulmonary arterial hypertension (PAH). Most mutations have been identified in the gene BMPR2 in heritable PAH. However, as of today 15 further PAH genes have been described. The exact prevalence across these genes particularly in other PAH forms remains uncertain. We present the distribution of mutations across PAH genes identified at the largest German referral centre for genetic diagnostics in PAH over a course of > 3 years. Methods Our PAH-specific gene diagnostics panel was used to sequence 325 consecutive PAH patients from March 2017 to October 2020. For the first year the panel contained thirteen PAH genes: ACVRL1, BMPR1B, BMPR2, CAV1, EIF2AK4, ENG, GDF2, KCNA5, KCNK3, KLF2, SMAD4, SMAD9 and TBX4.These were extended by the three genes ATP13A3, AQP1 and SOX17 from March 2018 onwards following the genes' discovery. Results A total of 79 mutations were identified in 74 patients (23%). Of the variants 51 (65%) were located in the gene BMPR2 while the other 28 variants were found in ten further PAH genes. We identified disease-causing variants in the genes AQP1, KCNK3 and SOX17 in families with at least two PAH patients. Mutations were not only detected in patients with heritable and idiopathic but also with associated PAH. Conclusions Genetic defects were identified in 23% of the patients in a total of 11 PAH genes. This illustrates the benefit of the specific gene panel containing all known PAH genes.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | PRESSURE RESPONSE; BETA-RECEPTOR; MUTATIONS; IDENTIFICATION; Pulmonary arterial hypertension; Genetic testing; Bi-allelic variants; Gene panel diagnostics |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin II |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 13 Dec 2023 07:27 |
| Last Modified: | 13 Dec 2023 07:27 |
| URI: | https://pred.uni-regensburg.de/id/eprint/58723 |
Actions (login required)
 |
View Item |
